| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| North America Biopreservation Market Size 2023 |
USD 765.99 million |
| North America Biopreservation Market, CAGR |
24.65% |
| North America Biopreservation Market Size 2032 |
USD 7,198.57 million |
Market Overview
The North America Biopreservation Market is projected to grow from USD 765.99 million in 2023 to an estimated USD 7,198.57 million by 2032, with a compound annual growth rate (CAGR) of 24.65% from 2024 to 2032. This growth is driven by increasing demand for biopreservation techniques in the pharmaceutical, biotechnology, and healthcare sectors, as well as the growing need for preserving biological samples and tissues.
Key market drivers include the increasing focus on preserving biological materials such as stem cells, enzymes, and vaccines, which is crucial for research and development. Additionally, the rising demand for blood plasma and the growing importance of genetic studies and biobanks are further propelling the market. Trends such as the integration of artificial intelligence in biopreservation and the development of automated storage systems are also shaping the market’s growth trajectory, contributing to higher efficiency and reduced human error.
Geographically, North America is expected to maintain its leadership in the biopreservation market due to a robust healthcare infrastructure, significant investments in research and development, and strong government support. The U.S. remains the largest contributor, with a high concentration of biopharmaceutical companies, academic institutions, and biobanks. Key players in the market include Thermo Fisher Scientific Inc., BioLife Solutions, Inc., VWR International, and Chart Industries, Inc., who are investing in innovations to strengthen their position in this rapidly expanding market.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Insights
- The North America Biopreservation Market is projected to grow significantly, from USD 765.99 million in 2023 to USD 7,198.57 million by 2032, driven by advancements in preservation techniques and increased demand for biological sample storage.
- Key drivers include rising demand for biopreservation in pharmaceuticals, biotechnology, and healthcare sectors, alongside the growing adoption of personalized medicine and regenerative therapies.
- The need for preserving biological materials such as stem cells, enzymes, vaccines, and blood plasma is propelling the market, supporting research and development initiatives.
- Innovations in cryopreservation, AI integration, and automated storage systems are enhancing the efficiency and effectiveness of biopreservation, reducing human error and improving sample integrity.
- High costs associated with advanced biopreservation technologies, as well as complex regulatory compliance requirements, can limit market growth, especially for smaller companies or institutions.
- North America, particularly the U.S., leads the global biopreservation market due to its robust healthcare infrastructure, strong research focus, and government support, with Canada following closely behind.
- The market is competitive, with key players such as Thermo Fisher Scientific Inc., BioLife Solutions, and VWR International focusing on technological innovations and strategic partnerships to strengthen their market positions.
Market Drivers
Increasing Demand for Biobanking and Cryopreservation
One of the primary drivers of the North America Biopreservation Market is the growing need for biobanking and cryopreservation across various sectors, including healthcare, biotechnology, and pharmaceuticals. Biobanks, which store biological samples for research purposes, have gained significant traction in recent years. They are crucial for advancing medical research, genetic studies, and personalized medicine. For instance, the Hastings Center reports that approximately 300 million biospecimens are stored in various public and private biobanks across the United States, highlighting the extensive utilization of biobanking in medical research and genetic studies. This significant volume of stored samples is essential for advancing research in areas such as regenerative medicine and treatment for genetic disorders, emphasizing the critical role of biobanks in healthcare innovation.Biopreservation technologies such as cryopreservation are essential in maintaining the integrity of biological samples, including blood, tissues, stem cells, and organs. As the demand for biobanks continues to rise, the need for efficient, reliable, and scalable biopreservation solutions is intensifying. The expansion of biobanks is being fueled by the growing importance of genetic research, the need to collect biological data for public health, and the ongoing exploration of personalized medicine. Furthermore, the increasing number of clinical trials—especially those focused on genetic therapies, cell therapies, and organ transplantation—has created an enormous demand for biobanks to store and manage biological samples. In response to this growing demand, biobanks are adopting advanced biopreservation technologies that ensure long-term storage and preservation of biological materials with minimal degradation.
Advancements in Cryopreservation and Storage Technologies
Advancements in cryopreservation and biopreservation technologies are another significant factor driving the growth of the North America Biopreservation Market. Cryopreservation involves freezing biological materials at ultra-low temperatures to preserve their structure and functionality for future use. Over the years, technological improvements have made cryopreservation more efficient and cost-effective, with reduced risks of cellular damage during the freezing and thawing processes. Innovations such as automated cryopreservation systems and improved thawing techniques have contributed to increased adoption of these technologies across various industries.Cryopreservation is particularly vital in fields like regenerative medicine, where stem cells and tissues need to be preserved for extended periods without losing their therapeutic potential. The pharmaceutical and biotechnology industries also heavily rely on cryopreservation to store critical biological materials, including vaccines, proteins, enzymes, and antibodies. Moreover, the development of new cryoprotectants and the refinement of freezing protocols have improved the long-term stability and viability of preserved biological materials, further driving market growth. These advancements not only enhance the capabilities of biopreservation but also reduce the overall cost of storing biological materials, making it more accessible to a broader range of institutions.
Growth in Personalized Medicine and Cell Therapy
The rise of personalized medicine and cell therapy is a major factor influencing the demand for biopreservation solutions in North America. Personalized medicine tailors treatments based on individual genetic profiles, which often requires the use of preserved biological samples for genetic analysis. The ability to preserve these samples accurately and safely is essential for developing targeted therapies that address specific patient needs. Biopreservation technologies such as cryopreservation and controlled-rate freezing are integral to maintaining the integrity of genetic material and other biological components used to create personalized treatment plans.Additionally, cell therapy—which involves using living cells to treat various medical conditions—is another rapidly growing field that relies heavily on biopreservation. The preservation of stem cells, immune cells, and other therapeutic cells is critical to their effectiveness when used in clinical applications. As demand for cell-based therapies increases, so does the need for advanced biopreservation solutions capable of ensuring the viability and potency of these cells over extended periods. Furthermore, increasing investment in developing gene therapies—which often require preserving viral vectors and other sensitive biological materials—is propelling demand for biopreservation technologies.
Rising Demand for Blood Plasma and Organ Transplantation
The rising demand for blood plasma and the growing need for organ transplantation are also key drivers of the North America Biopreservation Market. Blood plasma is used in various therapeutic applications—including immunoglobulin replacement therapy, clotting factor replacement, and treatment for burn victims. Biopreservation is essential for maintaining the quality and safety of blood plasma, ensuring it remains viable for clinical use. The increasing demand for plasma-derived therapies—driven by an aging population and prevalence of chronic diseases—has significantly contributed to market growth.Similarly, organ transplantation continues to be a critical area of medical treatment; preserving organs for transplant is a crucial process in this field. Biopreservation technologies such as hypothermic storage and organ perfusion are used to extend organ viability during transplantation. With an increasing number of organ transplant surgeries alongside a shortage of available organs, efficient preservation methods have become more urgent. Additionally, advances in preservation techniques have improved organ transplant success rates—driving demand for more sophisticated biopreservation solutions. This trend is expected to continue as both blood plasma needs and organ transplantation demands rise in North America.
Market Trends
Integration of Artificial Intelligence and Automation in Biopreservation Processes
One of the most prominent trends in the North America Biopreservation Market is the integration of artificial intelligence (AI) and automation into biopreservation technologies. With the increasing complexity of preserving biological materials such as stem cells, tissues, and organs, the demand for more efficient and reliable methods of storage and management has grown significantly. AI-driven systems and automation tools are now being used to optimize biopreservation processes by improving accuracy, reducing human error, and enhancing the overall efficiency of storage facilities. For instance, AI-driven systems are increasingly utilized in biobanks to enhance the accuracy and efficiency of sample management. These systems can automatically monitor environmental conditions, such as temperature and humidity, ensuring that biological samples remain in optimal storage conditions without manual oversight. This capability significantly reduces the risk of human error, which is critical for maintaining sample integrity over time. Moreover, automated cryopreservation technologies exemplify this trend by providing precise control over freezing and thawing processes. Such systems can adjust parameters in real-time based on continuous monitoring, which is essential for preserving the viability of sensitive biological materials like stem cells and tissues.AI technologies also play a pivotal role in managing large-scale biobanks, where vast amounts of biological samples are stored. These intelligent systems help track and manage the location, condition, and viability of samples with real-time monitoring and predictive analytics. By analyzing data from the preservation environment, AI systems can anticipate issues related to sample degradation or storage conditions, enabling proactive adjustments. This level of automation not only increases the throughput of preservation activities but also reduces labor costs and minimizes human intervention. As automation becomes more prevalent, companies are increasingly investing in AI-based solutions to streamline operations and ensure high standards of biopreservation.
Increased Focus on Sustainable Biopreservation Practices
As sustainability becomes a central concern in various industries, the biopreservation sector is also adapting to environmental considerations by adopting greener, more sustainable practices. Traditional biopreservation methods, particularly cryopreservation, involve the use of cryoprotectants and large volumes of liquid nitrogen, which can have environmental impacts. As such, the industry is shifting towards more sustainable alternatives that minimize waste and energy consumption. Researchers and biopreservation solution providers are focusing on developing eco-friendly cryoprotectants and refrigeration systems that reduce reliance on harmful chemicals and energy-intensive processes.The movement towards sustainable biopreservation is particularly relevant in the context of growing environmental regulations and the global push for greener technologies. Companies are now prioritizing the design of preservation solutions that use renewable energy sources, reduce carbon footprints, and improve overall energy efficiency in storage facilities. Additionally, companies are exploring techniques such as low-temperature storage using solid-state devices that offer lower energy consumption compared to traditional methods. This trend is expected to drive innovation in the field, with companies striving to offer biopreservation solutions that are both environmentally responsible and commercially viable.
Expansion of Biopreservation Applications in Personalized Medicine and Cell Therapy
Personalized medicine and cell therapy are two rapidly growing fields in the healthcare industry, and their expansion is significantly influencing trends in the biopreservation market. Personalized medicine tailors treatments to individual genetic profiles, often relying on preserved biological materials such as blood, tissues, or DNA samples. For these treatments to be effective, accurate and long-term preservation of biological samples is crucial. The demand for biopreservation technologies that can handle increasingly complex and sensitive biological materials while ensuring their quality and viability has escalated as personalized medicine gains momentum.Similarly, cell therapy—which uses living cells to treat various diseases including cancer and autoimmune conditions—is a key driver of the market. Cells used in these therapies need to be stored for extended periods without losing their functionality, making biopreservation a critical part of the process. Advances in cryopreservation and cell storage technologies, such as automated freezing and thawing systems, are enabling companies to store cells at optimal conditions, ensuring that they retain their therapeutic efficacy when used in clinical applications. The rise of gene therapies, which require the preservation of viral vectors, further increases the need for advanced biopreservation technologies. As personalized medicine and cell therapies continue to evolve, the demand for innovative and efficient biopreservation solutions is expected to increase.
Growth of Biobanks and Increased Investment in Biopreservation Infrastructure
Biobanks—facilities that store biological samples for use in research and clinical applications—are experiencing rapid growth in North America, driving demand for advanced biopreservation solutions. Biobanks are increasingly being established to support genomic research, drug development, and disease prevention programs. With a growing need for long-term storage of a variety of biological materials including blood, plasma, tissues, and DNA, biobanks require highly reliable and scalable biopreservation systems to ensure sample integrity over time.This trend has led to a significant rise in investment in biopreservation infrastructure; biobanks and research institutions are allocating substantial resources to improve their storage capabilities. Advanced biopreservation technologies such as cryopreservation tanks, liquid nitrogen-based storage systems, and advanced refrigeration units are being adopted to meet the growing needs of biobanks. Additionally, new biobanks are being established across the U.S. and Canada to address increasing demands for clinical trials, genetic studies, and research on rare diseases. The increasing focus on research collaborations, biopharmaceutical development, and precision medicine has led to a surge in public and private investments in biopreservation technologies. As a result, the development of state-of-the-art biopreservation facilities is expected to continue driving growth in the market.
Market Challenges
High Cost of Biopreservation Technologies and Infrastructure
One of the significant challenges facing the North America Biopreservation Market is the high cost associated with advanced biopreservation technologies and infrastructure. The implementation of state-of-the-art systems, including automated cryopreservation, temperature-controlled storage units, and sophisticated monitoring equipment, requires substantial capital investment. Additionally, the need for high-quality cryoprotectants and other consumables further contributes to the overall cost of biopreservation processes. Smaller institutions and emerging biotechnological companies, in particular, may find these expenses prohibitive, limiting their ability to adopt advanced preservation techniques. Furthermore, the maintenance and operation of biopreservation facilities also entail ongoing costs, including energy-intensive systems that rely on liquid nitrogen or refrigeration units, which are both costly and environmentally challenging. These expenses can act as a barrier for smaller-scale research operations and biobanks, restricting access to high-quality preservation technologies. As the demand for biopreservation continues to grow, particularly in areas like personalized medicine and cell therapy, addressing the affordability of these technologies will be crucial to ensure broader adoption and support for smaller players in the market.
Regulatory and Compliance Challenges
Another significant challenge in the North America Biopreservation Market is navigating the complex regulatory and compliance landscape. Biopreservation technologies, particularly those used in clinical applications such as cell therapy, organ transplantation, and gene therapy, are subject to stringent regulations enforced by agencies such as the U.S. Food and Drug Administration (FDA) and Health Canada. Compliance with these regulations requires biopreservation providers to maintain rigorous quality control processes, ensure the safety of preserved biological materials, and adhere to protocols for storage, handling, and transportation. In addition, evolving regulatory frameworks and the varying standards across regions add complexity for businesses operating in multiple jurisdictions. The need for continuous updates and adjustments to meet changing regulatory requirements can result in significant operational delays and additional costs. This challenge is particularly relevant as new biopreservation techniques and materials are developed and introduced into the market, necessitating thorough testing, certification, and approval processes. As the industry advances, addressing regulatory hurdles and maintaining compliance while ensuring the safety and efficacy of biopreservation technologies will be essential to sustaining market growth.
Market Opportunities
Increasing Demand for Energy Efficiency and Power Quality Solutions
As industrial and commercial sectors focus more on energy efficiency and reducing power consumption, the demand for harmonic filters is rising. Harmonic distortion, often caused by the use of non-linear loads such as variable speed drives, computers, and other equipment, can lead to inefficiencies in power systems, reducing energy quality and increasing operational costs. Harmonic filters provide an effective solution to mitigate these distortions, improving power factor, minimizing energy losses, and enhancing the overall efficiency of electrical systems. As industries continue to adopt energy-efficient practices and technologies, particularly with the growing trend toward green building certifications and sustainability initiatives, the need for reliable harmonic filters is expected to grow. This trend creates a significant opportunity for manufacturers to develop and offer innovative harmonic filtering solutions to meet the evolving demands of the market.
Growth in Renewable Energy and Electrification Projects
The growing global shift toward renewable energy sources, such as solar, wind, and electric vehicles, presents a significant opportunity for the harmonic filter market. Renewable energy systems and electric vehicle charging stations often introduce harmonics into the power grid due to the inverter-based technologies used in these applications. As these technologies expand, there will be an increasing need for harmonic filters to ensure the stability and efficiency of the electrical grid. Additionally, ongoing electrification projects in sectors like transportation, agriculture, and residential buildings are expected to further drive the demand for harmonic filtering solutions. This transition to cleaner, electrified systems offers a substantial market opportunity for companies providing high-performance harmonic filters tailored to new and emerging electrical infrastructure.
Market Segmentation Analysis
By Type
The North America Biopreservation Market is seeing increasing demand for natural, microbial, and chemical preservatives, each offering unique benefits. Natural preservatives, derived from plant, animal, or microbial sources, are gaining popularity in the food and beverage industry, as consumers seek organic and clean-label products. These include substances like vinegar, salt, and essential oils, which help extend shelf life while maintaining product quality and minimizing environmental impact. Microbial preservatives, such as lactic acid bacteria and bacteriocins, are gaining traction as natural alternatives to chemical preservatives, particularly in food, pharmaceuticals, and cosmetics, driven by a preference for sustainable and natural solutions. On the other hand, chemical preservatives like sodium benzoate and potassium sorbate remain widely used due to their effectiveness in inhibiting microbial growth and prolonging shelf life, though consumer concerns about synthetic chemicals are pushing for a shift toward more natural options. Despite this trend, chemical preservatives continue to dominate in certain sectors, especially where cost-effectiveness and shelf life are prioritized.
By Application
The North America Biopreservation Market is experiencing significant growth across several key applications, including food and beverages, pharmaceuticals, and cosmetics. In the food and beverage sector, biopreservation technologies are crucial for extending shelf life while preserving quality, safety, and nutritional value, with a growing preference for natural and microbial preservatives driven by consumer demand for clean-label and organic products. Additionally, concerns about food waste and the need for sustainable preservation methods are fueling further market expansion. In the pharmaceutical industry, biopreservation plays an essential role in storing biological materials such as vaccines, blood, stem cells, and tissues, with increasing demand driven by the rise of biopharmaceuticals, personalized medicine, and the need for long-term storage of samples for clinical research. The cosmetics sector is also seeing a rise in the use of biopreservation, as consumers demand safer, eco-friendly products. Biopreservation solutions help extend the shelf life of cosmetics, particularly in organic and natural skincare, where chemical preservatives are being replaced by natural alternatives.
Segments
Based on Type
- Natural Preservatives
- Microbial Preservatives
- Chemical Preservatives
Based on Application
- Food and Beverages
- Pharmaceuticals
- Cosmetics
Based on Region
Regional Analysis
United States (85%):
The United States holds the largest market share in the North America Biopreservation Market, accounting for approximately 85% of the total market value. The country’s dominance can be attributed to its advanced healthcare infrastructure, high investments in research and development, and strong regulatory frameworks that foster innovation in biopreservation technologies. Additionally, the U.S. benefits from a large number of biopharmaceutical companies, research institutions, and clinical trial organizations, all of which rely heavily on biopreservation techniques to maintain the integrity of biological materials such as stem cells, vaccines, and blood plasma. The increasing demand for biobanks, personalized medicine, and regenerative medicine further fuels market growth in the region. Moreover, the United States continues to lead the way in clinical research, particularly in areas like cancer immunotherapy, cell-based therapies, and gene therapies. As these sectors continue to expand, the need for advanced biopreservation technologies, including cryopreservation and microbial preservation, is expected to grow. The country’s focus on sustainable and green technologies in various industries, such as food and beverages and pharmaceuticals, also plays a role in driving the adoption of more environmentally friendly preservation solutions.
Canada (15%):
Canada, while smaller in comparison, represents a rapidly growing segment of the North America Biopreservation Market, with an estimated market share of around 15%. The Canadian market benefits from a robust healthcare system, a growing biotechnology sector, and increasing demand for biopreservation solutions, especially in the food and beverage industry. Canada’s regulatory environment supports the development of biopharmaceuticals, with a strong focus on research and development, particularly in the fields of genomics and personalized medicine. The rise of biobanks and clinical research centers further propels the demand for effective biopreservation techniques to store and manage biological samples. Canada is also witnessing an increasing demand for biopreservation technologies in the cosmetics and personal care industries, as consumers become more conscious of the ingredients used in skincare products and demand safer, more sustainable formulations. The country’s focus on environmental sustainability and reducing waste also supports the trend toward adopting natural and microbial preservatives in both the food and cosmetics sectors.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key players
- DuPont de Nemours, Inc.
- BASF SE
- Kerry Group plc
- Hansen Holding A/S
- Mitsubishi Chemical Holdings Corporation
- SABIC
- BioCare Copenhagen
- MGP Ingredients, Inc.
- Agilent Technologies, Inc.
- Kemin Industries, Inc.
Competitive Analysis
The North America Biopreservation Market is highly competitive, with key players focusing on innovation, product development, and strategic collaborations to strengthen their market position. DuPont de Nemours, Inc. and BASF SE are leading players, leveraging their extensive product portfolios and strong research and development capabilities to meet the increasing demand for natural and chemical preservatives. Companies like Kerry Group plc and Chr. Hansen Holding A/S are capitalizing on the growing preference for natural and sustainable biopreservation solutions, focusing on clean-label and eco-friendly products. Mitsubishi Chemical Holdings Corporation and SABIC contribute with advanced chemical preservatives, catering to a range of industries from food to pharmaceuticals. Agilent Technologies and Kemin Industries emphasize the use of cutting-edge technologies, such as AI and automation, to improve biopreservation efficiency. The competitive landscape is shaped by these players’ focus on quality, sustainability, and technological advancement.
Recent Developments
- In October 2024, BASF introduced a novel biopreservation solution that utilizes advanced polymer technology to improve the stability of biological materials during storage and transport.
- In September 2024, Kerry Group launched an innovative biopreservation product aimed at enhancing the shelf life and quality of cultured cells used in regenerative medicine.
- In August 2024, Mitsubishi Chemical launched a new line of cryopreservation equipment specifically designed for the storage of stem cells and other biological materials in healthcare facilities across the Middle East.
- In June 2024, BioCare Copenhagen expanded its operations in the Middle East by launching a new facility dedicated to biopreservation solutions for clinical applications.
- In April 2024, Agilent Technologies launched an advanced laboratory information management system (LIMS) tailored for biobanks and biopreservation facilities to streamline sample management processes.
- In March 2024, Kemin Industries announced the development of a new line of natural preservatives designed to enhance the stability and longevity of biological samples used in research.
Market Concentration and Characteristics
The North America Biopreservation Market exhibits moderate to high market concentration, with several key players dominating the space, including DuPont de Nemours, Inc., BASF SE, Kerry Group plc, and Chr. Hansen Holding A/S. These companies lead through a combination of strong research and development capabilities, extensive product portfolios, and strategic acquisitions or partnerships to enhance their market presence. The market is characterized by a growing demand for natural, sustainable, and effective biopreservation solutions, driven by industries such as pharmaceuticals, food and beverages, and cosmetics. With increasing focus on clean-label products and environmentally-friendly preservatives, the market is evolving toward more sustainable and cost-effective solutions. Additionally, the rise of biotechnological advancements, such as cryopreservation and microbial preservation, is shaping the competitive dynamics, where innovation and product differentiation are key to securing market leadership. The concentration of market players ensures a competitive environment focused on quality, compliance, and customer-centric offerings.
Report Coverage
The research report offers an in-depth analysis based on Type, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The North America Biopreservation Market is expected to witness continued innovation, particularly in cryopreservation and microbial preservation technologies. These advancements will enhance the efficiency and scalability of biopreservation solutions across various industries.
- With the rise of personalized medicine, there will be an increasing need for advanced biopreservation technologies to store genetic samples and biologics. This demand will drive the growth of biopreservation solutions tailored to the pharmaceutical and healthcare sectors.
- The expansion of biobanks in North America will accelerate the demand for biopreservation technologies, particularly in medical research and clinical trials. Biobanks will play a critical role in preserving biological materials for genetic studies and drug development.
- As sustainability becomes a key focus, the biopreservation market will shift toward eco-friendly, natural, and organic preservatives. This trend will reshape the food and beverage industry, fostering demand for cleaner and greener preservation solutions.
- Strong regulatory frameworks in North America, especially in the U.S. and Canada, will encourage the growth of the biopharmaceutical industry, further fueling the demand for biopreservation technologies in drug development and biomanufacturing.
- The growing consumer preference for natural and preservative-free cosmetics will create new opportunities for biopreservation in the personal care industry. Innovations in microbial preservatives will drive this shift.
- Ongoing investments in biotechnology and medical research will propel the need for advanced biopreservation solutions. Research institutions and clinical labs will require robust preservation technologies for long-term storage of biological samples.
- The rising demand for organ transplantation will drive the need for advanced preservation solutions to ensure the viability of organs. Biopreservation technologies will play a key role in improving the success rates of organ transplants.
- Automation and AI are set to transform the biopreservation market by enhancing storage management, reducing human error, and improving the overall efficiency of preservation processes, especially in large-scale applications like biobanks.
- The growing aging population in North America will contribute to the demand for preserved biological materials, such as blood and stem cells, to treat age-related diseases. Biopreservation will become essential in meeting this healthcare challenge
